Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.6500
+0.1118 (20.76%)
Oct 24, 2025, 10:27 AM EDT
Pharma-Bio Serv Revenue
Pharma-Bio Serv had revenue of $1.96M in the quarter ending July 31, 2025, a decrease of -18.82%. This brings the company's revenue in the last twelve months to $9.18M, down -14.75% year-over-year. In the fiscal year ending October 31, 2024, Pharma-Bio Serv had annual revenue of $9.51M, down -43.99%.
Revenue (ttm)
9.18M
Revenue Growth
-14.75%
P/S Ratio
1.62
Revenue / Employee
122.46K
Employees
75
Market Cap
14.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 9.51M | -7.47M | -43.99% |
| Oct 31, 2023 | 16.98M | -2.42M | -12.48% |
| Oct 31, 2022 | 19.40M | -716.45K | -3.56% |
| Oct 31, 2021 | 20.12M | -1.45M | -6.72% |
| Oct 31, 2020 | 21.56M | 2.06M | 10.55% |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| QT Imaging Holdings | 8.26M |
| Northwest Biotherapeutics | 1.09M |
Pharma-Bio Serv News
- 5 weeks ago - Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025 - Accesswire
- 4 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025 - Accesswire
- 7 months ago - Pharma-Bio Serv reports revenue of $2.5 million for quarter ended January 31, 2025 - Seeking Alpha
- 7 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025 - Accesswire
- 9 months ago - Pharma-Bio Serv reports FY results - Seeking Alpha
- 9 months ago - Pharma-Bio Serv declares $0.075 dividend - Seeking Alpha
- 9 months ago - Pharma-Bio Serv Announces Full Year Results - Accesswire
- 9 months ago - Pharma-Bio Serv Announces Special Dividend - Accesswire